Cubist Systematic Strategies’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-90,012
| Closed | -$1.23M | – | 4707 |
|
|
2022
Q4 | $1.23M | Sell |
90,012
-81,987
| -48% | -$1.14M | 0.01% | 2263 |
|
|
2022
Q3 | $2.38M | Sell |
171,999
-146,512
| -46% | -$2.18M | 0.01% | 1824 |
|
|
2022
Q2 | $4.57M | Buy |
318,511
+271,649
| +580% | +$4.71M | 0.03% | 1066 |
|
|
2022
Q1 | $1.06M | Sell |
46,862
-129,996
| -74% | -$2.52M | 0.01% | 1982 |
|
|
2021
Q4 | $3.32M | Buy |
176,858
+162,417
| +1,125% | +$4.34M | 0.03% | 942 |
|
|
2021
Q3 | $474K | Buy |
14,441
+7,992
| +124% | +$298K | 0.01% | 2071 |
|
|
2021
Q2 | $275K | Sell |
6,449
-786
| -11% | -$30.7K | ﹤0.01% | 2391 |
|
|
2021
Q1 | $277K | Sell |
7,235
-2,712
| -27% | -$115K | ﹤0.01% | 2303 |
|
|
2020
Q4 | $435K | Sell |
9,947
-24,772
| -71% | -$932K | 0.01% | 1847 |
|
|
2020
Q3 | $1.37M | Buy |
34,719
+8,565
| +33% | +$277K | 0.02% | 1152 |
|
|
2020
Q2 | $825K | Buy |
26,154
+10,414
| +66% | +$389K | 0.01% | 1300 |
|
|
2020
Q1 | $554K | Sell |
15,740
-213
| -1% | -$8.98K | 0.02% | 1190 |
|
|
2019
Q4 | $775K | Sell |
15,953
-11,825
| -43% | -$538K | 0.01% | 1313 |
|
|
2019
Q3 | $1.32M | Buy |
27,778
+13,529
| +95% | +$636K | 0.03% | 840 |
|
|
2019
Q2 | $612K | Sell |
14,249
-824
| -5% | -$32K | 0.01% | 1349 |
|
|
2019
Q1 | $583K | Buy |
15,073
+968
| +7% | +$32.8K | 0.02% | 1086 |
|
|
2018
Q4 | $402K | Buy |
+14,105
| New | +$448K | 0.02% | 1093 |
|
|
2018
Q3 | – | Sell |
-3,062
| Closed | -$99K | – | 2148 |
|
|
2018
Q2 | $99K | Sell |
3,062
-1,246
| -29% | -$34.3K | 0.01% | 1539 |
|
|
2018
Q1 | $94K | Buy |
4,308
+3,765
| +693% | +$90.5K | 0.01% | 1604 |
|
|
2017
Q4 | $13K | Sell |
543
-4,118
| -88% | -$104K | ﹤0.01% | 1847 |
|
|
2017
Q3 | $131K | Buy |
4,661
+256
| +6% | +$7.79K | 0.01% | 1576 |
|
|
2017
Q2 | $142K | Sell |
4,405
-3,411
| -44% | -$104K | 0.01% | 1384 |
|
|
2017
Q1 | $221K | Buy |
+7,816
| New | +$208K | 0.02% | 1116 |
|
|
2016
Q4 | – | Sell |
-9,543
| Closed | -$227K | – | 1939 |
|
|
2016
Q3 | $227K | Buy |
+9,543
| New | +$209K | 0.01% | 1183 |
|
|
2015
Q4 | – | Sell |
-13,800
| Closed | -$219K | – | 2009 |
|
|
2015
Q3 | $219K | Buy |
13,800
+12,800
| +1,280% | +$323K | 0.01% | 1419 |
|
|
2015
Q2 | $26K | Buy |
+1,000
| New | +$32.3K | ﹤0.01% | 1747 |
|
|
2014
Q4 | – | Sell |
-2,700
| Closed | -$64K | – | 2093 |
|
|
2014
Q3 | $64K | Buy |
2,700
+1,334
| +98% | +$37.9K | ﹤0.01% | 1609 |
|
|
2014
Q2 | $43K | Buy |
+1,366
| New | +$39.4K | ﹤0.01% | 1416 |
|
Other funds holding CSII
BCM
CIP
PCM
WIC
AAM
GF
Cubist Systematic Strategies's CSII Position: Q1 2023 in Review
Cubist Systematic Strategies sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 90,012 shares — an estimated $1.23M sold.
Cubist Systematic Strategies first reported a position in CSII in Q2 2014 and held it in 28 quarters. The position peaked at $4.57M in Q2 2022. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.
- Cubist Systematic Strategies reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 90,012 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $1.23M.
- Cubist Systematic Strategies first reported a position in Cardiovascular Systems, Inc. in Q2 2014 and held it in 28 quarters.
- Cubist Systematic Strategies's Cardiovascular Systems, Inc. position peaked at $4.57M in Q2 2022.
- 150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.
Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.